Linked issuers
4
Insider Ownership Activity for Erin Lavelle
SEC Forms 3/4/5 positions, issuer links, and transaction evidence for this reporting owner.
Largest position
Avalyn Pharma Inc.
Disclosed value
—
Transaction activity
Available
- Reporting-owner location
- Waltham, MA
- Latest reporting-owner signature
-
/s/ Elizabeth Balta, as attorney-in-fact for Erin Lavelle
Source: Latest parsed Forms 3/4/5 signature
- Source filing history
-
Open source filing history
Source: SEC Forms 3/4/5Freshness: Reporting-owner filing trail
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Follow Filing Activity
Follow Erin Lavelle and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Erin Lavelle
AVLN
Forms 3/4/5
Avalyn Pharma Inc.
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 29 Apr 2026
CLYM
Forms 3/4/5
Eliem Therapeutics, Inc.
- Relationship
- Coo & Cfo
- Holdings value
- Past year net change
- Change %
- Report period
- 31 Oct 2022
JBIO
Forms 3/4/5
Jade Biosciences, Inc.
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 09 Jun 2026
NGNE
Forms 3/4/5
Neoleukin Therapeutics, Inc.
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 08 Jun 2023
Recent insider transactions for Erin Lavelle
| Sym | Company | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.